Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update
Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these results with investors at the 39th Annual J.P. Morgan Virtual Healthcare Conference. Novocure also plans to highlight key clinical and product development programs.
Fourth quarter and full year 2020 highlights include: |
||||||||||||||||||||||||||||||||||||||
|
Three months ended
|
|
Twelve months ended
|
|
||||||||||||||||||||||||||||||||||
|
|
2020 |
|
|
2019 |
|
% Change |
|
|
2020 |
|
|
2019 |
|
% Change |
|
||||||||||||||||||||||
|
|
(unaudited) |
|
|
(audited) |
|||||||||||||||||||||||||||||||||